No. Current AAPM guidance recommends discontinuing routine patient gonadal and fetal shielding during X-ray diagnostic imaging because shields can obscure anatomy, interfere with automatic exposure control and in some cases increase dose. Facilities should follow current professional guidance and applicable local requirements.
Product knowledge centre
Frequently Asked Questions About Gonad & Ovarian Shields
Find practical answers about product selection, specifications, intended use, ordering and support for Gonad & Ovarian Shields.
Questions & answers
Gonad & Ovarian Shields FAQ directory
Use the search box to quickly find a question, or expand the answers individually.
5
answers available
An imaging professional may consider shielding in an exceptional, policy-driven or anxiety-management situation only when it will not compromise the examination. The decision should be made by the responsible clinical/radiology team rather than applied automatically.
The current published product range includes 0.50 mmPb and 1.00 mmPb options. Review the individual product page and active variant information for the exact configuration and core material.
Yes. A shield can obscure diagnostically important anatomy or interact with automatic exposure control if it is placed in or near the imaging field. Correct positioning and current imaging policy are therefore essential.
Follow the facility's procedure for reusable radiation-protection products. Avoid unnecessary sharp folding or compression, inspect the outer covering and protective core according to institutional policy, and remove damaged items from use pending assessment.
No matching question found
Try a shorter search term, browse the full list, or contact IndoSurgicals for product assistance.
Need product-specific guidance?
Share your intended use and required quantity
Our team can help you review suitable specifications, availability and quotation requirements for Gonad & Ovarian Shields.